Top in allergy/asthma: Cephalosporin safe with penicillin allergy; asthma and mycobacteria

Cephalosporins could be a safe alternative for patients with penicillin allergy, according to a small study of patients from the Yale New Haven Hospital Health System.

It was the top story in allergy/asthma last week.

The second top story was about patients with asthma or allergic rhinitis being at greater risk for mycobacterial disease than patients without allergic diseases. Age and BMI were also factors that affected the risk for mycobacterial disease.

Read these and more top stories in allergy/asthma below:

Cephalosporin appears safe in patients with verified penicillin allergy

High-risk patients with a verified penicillin allergy safely received cephalosporins, according to a letter published in The Journal of Allergy and Clinical Immunology: In Practice. Read more.

Asthma, allergic rhinitis associated with risks for mycobacterial disease

Patients with asthma or allergic rhinitis had greater risk for mycobacterial disease than patients who did not have these allergic diseases, according to a recent study. Nicole Soucy, PA-C, weighed in with a perspective. Read more.

Symptoms resolve with dupilumab in patients with drug reactions

Dupilumab may be a safe and effective therapy for patients with drug reactions with eosinophilia and systemic symptoms, or DRESS, researchers said. Christopher Brooks, MD, and Cosby A. Stone Jr., MD, MPH, offered their reaction to the study. Read more.

Gut microbiome changes precede eczema development in infancy

Changes in the gut microbiota of infants preceded the development of eczema, according to a study published in mSystems. Read more.

Children with food allergy experience greater odds for food insecurity

Children with food allergy had greater risks for food insecurity, underscoring the need to assess for food insecurity in allergy practices, according to researchers. Read more.